New tools for multiple myeloma treatment monitoring
Bruno Paiva et al.
Overcoming mental health issues for patients with CLL
Are IDH mutations good minimal residual disease (MRD) markers in acute myeloid leukemia (AML)?
How can patients be advised about working with medical conditions?
Personalising treatment to the biology of the NHL patient